(VIANEWS) – NV5 Global (NVEE), Comfort Systems USA (FIX), Ituran Location and Control Ltd. (ITRN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NV5 Global (NVEE)
17.5% sales growth and 6.96% return on equity
NV5 Global, Inc. provides professional and technical engineering and consulting services to public and private sector clients in the infrastructure, utility services, construction, real estate, and environmental markets in the United States and internationally. It operates through three segments: Infrastructure; Building, Technology & Sciences; and Geospatial Solutions. The company offers site selection and planning, design, water resources, transportation, structural engineering, land development, surveying, power delivery, building code compliance, and other services; and construction materials testing and engineering, geotechnical engineering and consulting, and forensic consulting services. It also provides governmental outsourcing and consulting, and technical outsourcing services; and geospatial data analytic and mapping services. In addition, the company offers mechanical, electrical, and plumbing design; commissioning; energy performance, management, and optimization; building program management; acoustical design consulting; and audiovisual–security and surveillance–information technology–data center services, as well as energy services. Further, it provides various services, such as investigating and analyzing environmental conditions, and recommending corrective measures and procedures; occupational health and safety services; radiation exposure and protection, and nuclear safety and industrial hygiene analyses services; hydrogeological modeling and environmental programs; water resource planning, monitoring, and environmental management of wastewater facilities; solid waste landfill investigations; permitting and compliance; storm water pollution; environmental impact statement support; agricultural waste management and permitting; and wetland evaluations. The company was formerly known as NV5 Holdings, Inc. and changed its name to NV5 Global, Inc. in December 2015. NV5 Global, Inc. was founded in 1949 and is headquartered in Hollywood, Florida.
Earnings Per Share
As for profitability, NV5 Global has a trailing twelve months EPS of $3.07.
PE Ratio
NV5 Global has a trailing twelve months price to earnings ratio of 36.13. Meaning, the purchaser of the share is investing $36.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.96%.
Sales Growth
NV5 Global’s sales growth is 9.5% for the ongoing quarter and 17.5% for the next.
Moving Average
NV5 Global’s worth is above its 50-day moving average of $101.41 and below its 200-day moving average of $118.69.
2. Comfort Systems USA (FIX)
13.5% sales growth and 22.4% return on equity
Comfort Systems USA, Inc. provides mechanical and electrical installation, renovation, maintenance, repair, and replacement services for the mechanical and electrical services industry in the United States. It engages in the design, engineering, integration, installation, and start-up of mechanical, electrical, and plumbing (MEP) systems; and renovation, expansion, maintenance, monitoring, repair, and replacement of existing buildings. The company offers its services for heating, ventilation, and air conditioning (HVAC) systems, as well as plumbing, piping and controls, off-site construction, electrical, monitoring, and fire protection. It serves building owners and developers, general contractors, architects, consulting engineers, and property managers in the commercial, industrial, and institutional MEP markets. Comfort Systems USA, Inc. was founded in 1917 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Comfort Systems USA has a trailing twelve months EPS of $6.01.
PE Ratio
Comfort Systems USA has a trailing twelve months price to earnings ratio of 27.29. Meaning, the purchaser of the share is investing $27.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.4%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Comfort Systems USA’s EBITDA is 81.02.
Volume
Today’s last reported volume for Comfort Systems USA is 178112 which is 31% below its average volume of 258157.
3. Ituran Location and Control Ltd. (ITRN)
11.5% sales growth and 27.43% return on equity
Ituran Location and Control Ltd., together with its subsidiaries, provides location-based services and wireless communications products. The company's Location-Based Services segment provides stolen vehicle recovery and tracking services, which locate, track, and recover stolen vehicles for its subscribers; fleet management services that enable corporate and individual customers to track and manage their vehicles in real time; and personal locator services that allow customers to protect valuable merchandise and equipment. It also offers on-demand navigation guidance, information, and assistance, including the provision of traffic reports and directions, as well as information on the location of gas stations, car repair shops, post offices, hospitals, and other facilities; and Connected Car, service platform includes a back-office application, a telematics device installed in the vehicle, mobile apps for both IOS and Android users, as well as usage based insurance. This segment serves insurance companies and agents, car manufacturers, dealers and importers, cooperative sales channels, and private subscribers. Its Wireless Communications Products segment provides Base Site, a radio receiver that includes a processor and a data computation unit to collect and send data to and from transponders, and to control centers; Control Center, a center consisting of software used to collect data from various base sites, conduct location calculations, and transmit location data to various customers and law enforcement agencies; navigation and tracking devices installed in vehicles; and SMART, a portable transmitter installed in vehicles that sends a signal to the base site enabling the location of vehicles, equipment, or an individual. As of December 31, 2020, it served approximately 17,680,000 end-users in Israel, Brazil, Argentina, Mexico, Ecuador, Colombia, and the United States. The company was incorporated in 1994 and is headquartered in Azor, Israel.
Earnings Per Share
As for profitability, Ituran Location and Control Ltd. has a trailing twelve months EPS of $1.95.
PE Ratio
Ituran Location and Control Ltd. has a trailing twelve months price to earnings ratio of 13.75. Meaning, the purchaser of the share is investing $13.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.43%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 26, 2023, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 2.55%.
Moving Average
Ituran Location and Control Ltd.’s worth is way above its 50-day moving average of $23.18 and way above its 200-day moving average of $22.54.
Sales Growth
Ituran Location and Control Ltd.’s sales growth is 10.2% for the current quarter and 11.5% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 300.47M for the twelve trailing months.
4. United Therapeutics Corporation (UTHR)
5.5% sales growth and 15.66% return on equity
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhance the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. It has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder and Dreamboat devices; and Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Earnings Per Share
As for profitability, United Therapeutics Corporation has a trailing twelve months EPS of $14.82.
PE Ratio
United Therapeutics Corporation has a trailing twelve months price to earnings ratio of 15.1. Meaning, the purchaser of the share is investing $15.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.66%.
